Hue Rose Pham

Jun 23, 2023 | bioprocessonline.com | Erika Roberts |Ian Brown |Eleonora Bellissimi |Hue Rose Pham

By Erika L. Roberts, ELR Lab Services LLC Aptamers offer advantages over antibodies, including lower immunogenicity and toxicity, better tissue penetration, lower production costs, and a long shelf life. Why, then, have we not seen more of these come to market? Two hurdles have stood in the way until recently.